Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...
ARLINGTON, MA - January 06, 2026 - PRESSADVANTAGE - Drug testing in Chandler, AZ has shifted from a simple checkbox in ...
OLED technology creates sharper contrast and “pure” black levels, giving you the best possible picture. Editor's Note — ...
MyIQ is changing how digital culture engages with intelligence. In 2025, cognitive testing has become part of personal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback